Search Tufts Medicine

Displaying 121 - 140 of 163
Articles
January 10, 2020
MIRI Principal Investigator Michael House, MD will be collaborating in a study with funding from the CTSI Pilot Study Program.
department
Our team of dedicated physicians provides world-class patient care, research and training. We design the most effective and least invasive treatment plan tailored to each patient's individual needs.
Press Releases
January 7, 2021
Boston Magazine has honored 157 Tufts Medical Center physicians as 2021 Boston “Top Doctors.”
Press Releases
January 25, 2022
Boston Magazine has honored 154 Tufts Medical Center physicians as 2022 Boston “Top Doctors.”
Articles
December 12, 2023
We know the idea of needing surgery on your brain or spine can be scary, here’s how to find a neurosurgeon who will get you back to feeling your best.
page
...
Our researchers at the Center for the Evaluation of Value and Risk in Health (CEVR), including CEVR Director Peter J. Neumann, ScD, frequently contribute their knowledge to a wide range of prestigious, peer-reviewed journals.
Articles
December 5, 2019
Influenza (flu) is an unwelcome part of the holiday season, often spreading with the arrival of cold weather and sidelining many people from enjoying festive activities. However, by taking certain precautions we can ward off infections and stay healthy.
Articles
August 12, 2019
Third year Gastroenterology fellow at Tufts Medical Center, Sukeerti Kesar, MD, sprung to action to help Nico Pellegrino as he was having a heart attack.
Patient Stories
August 8, 2019
Nearly 1 year after being attacked by a great white shark, Dr. Lytton returned to Tufts Medical Center to share this story.
clinical trial
...

This research study is a 3-week clinical trial of dronabinol, a synthetic form of tetrahydrocannabinol (THC). This study is being done to determine if dronabinol is a safe and effective treatment for agitation symptoms related to Alzheimer’s disease. This study will compare dronabinol to a placebo.
Patient Stories
January 4, 2019
Phillipe doesn’t like to sit still. An architect at a firm in Boston’s Seaport, he’s used to being on the move – at work, at home and at the gym. In early 2018, he was forced to slow down when a debilitating back injury interfered with his busy life.
clinical trial
...

To demonstrate that remibrutinib is superior to teriflunomide in reducing the frequency of confirmed relapses.
clinical trial
...

The purpose of this study is to see if the study drug, elezanumab, is safe and able to improve function in patients with acute traumatic cervical spinal cord injury (SCI).